De Novo Discovery of Cysteine-Targeted Reversible Covalent Cyclic Peptides with Prolonged Residence Time via Phage Display
Journal of the American Chemical Society · 2026
DOI: 10.1021/jacs.6c17599 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2026. Verfasst von Yuqian Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Anti-Infective Drug Discovery and Development, School of Pharmaceutical Sciences, Sun Yat-Sen University Shenzhen Campus, She…. Hauptthemen laut MEDLINE: Peptides, Cyclic, Cysteine, Peptide Library. Die Arbeit nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, National Key Research and Development Program of China.
Abstract (Originalsprache)
Reversible covalent targeting of cysteine residues offers a powerful strategy for generating potent and tunable ligands, but designing electrophiles with balanced reactivity, stability, and reversible binding remains challenging. Here, we systematically optimized reversible α,β-unsaturated nitrile electrophiles and incorporated the selected warhead with prolonged residence time into phage-displayed peptides to construct a library of reversible covalent cyclic peptides. Screening this library against Keap1 enabled the de novo identification of ligands with nanomolar affinities, demonstrating a 5–100-fold improvement in binding potency relative to the corresponding noncovalent cyclic peptides. The most potent ligand, cyclic peptide 32, exhibits a Ki of 3.7 nM, retains binding under thiol-rich conditions, and can capture Keap1 from a complex cellular environment. Mechanistic analysis reveals that peptide-mediated targeting in cyclic peptide 32 positions the reversible covalent warhead to react rapidly with Keap1 Cys434 while maintaining prolonged residence, allowing covalent bond formation to keep pace with the transient binding dynamics of the peptide–protein interaction. Overall, this work establishes a general strategy for integrating tunable reversible covalent chemistry into genetically encoded peptide libraries, enabling de novo discovery of high-affinity ligands.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Anti-Infective Drug Discovery and Development, School of Pharmaceutical Sciences, Sun Yat-Sen University Shenzhen Campus, Shenzhen518107, China.
- The Fourth Affiliated Hospital, Guangzhou Medical University, Guangzhou511300, China.
- College of Chemistry, Chemical Engineering and Environment, Fujian Provincial Key Laboratory of Modern Analytical Science and Separation Technology, Micro-Nano Organic Optical Materials Laboratory, Minnan Normal Univers…
- Department of Chemistry, Changzhi University, Changzhi046011, China.
ORCID-Profile: Yiwu Zheng
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- National Key Research and Development Program of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- Shenzhen Medical Research Fund
Zitieren
APA
Zhang, Y., Qi, M., Liu, X., Zhou, Y., Wang, Y., Xiao, X., Wu, Y., Gao, W., Liu, Y., & Zheng, Y. (2026). De Novo Discovery of Cysteine-Targeted Reversible Covalent Cyclic Peptides with Prolonged Residence Time via Phage Display. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.6c17599
Vancouver
Zhang Y, Qi M, Liu X, Zhou Y, Wang Y, Xiao X, et al. De Novo Discovery of Cysteine-Targeted Reversible Covalent Cyclic Peptides with Prolonged Residence Time via Phage Display. Journal of the American Chemical Society. 2026. doi:10.1021/jacs.6c17599
BibTeX
@article{Zhang2026,
author = {Zhang, Yuqian and Qi, Mengzhu and Liu, Xiankai and Zhou, Yukun and Wang, Yanmei and Xiao, Xing and Wu, Yapei and Gao, Wei and Liu, Yang and Zheng, Yiwu},
title = {De Novo Discovery of Cysteine-Targeted Reversible Covalent Cyclic Peptides with Prolonged Residence Time via Phage Display},
journal = {Journal of the American Chemical Society},
year = {2026},
doi = {10.1021/jacs.6c17599}
}
EUVIMED